Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,814 shares at $280.20 ($1.1M) on 2022-04-08, disclosed to the SEC on 2022-04-12.
Open-market sale of $1.1M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $280.20 | 1,907 | $534K | 50.0% |
| 2 | $280.20 | 1,907 | $534K | 50.0% |
| Total | $280.20 avg | 3,814 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |